|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q1 FY2024
As of Mar 18, 2024
|
|
|---|---|---|---|
| Current assets | |||
| Cash and cash equivalents | |||
| Restricted cash | |||
| Prepayment and other current assets, net | |||
| Total current assets | |||
| Total assets | |||
| Current liabilities | |||
| Accrued expenses and other payables | |||
| Advance from customers | |||
| Warrant liability | |||
| Tax payable | |||
| Total current liabilities | |||
| Total liabilities | |||
| SHAREHOLDERS’ EQUITY | |||
| Common stock (90,000,000 Class A shares authorized; $0.005 par value; 14,318,410 shares issued and outstanding as of December 31, 2025; 5,065,150 shares issued and outstanding as of December 31, 2024) | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total shareholders’ equity | |||
| Total liabilities and shareholders’ equity |
Loading...
